We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal appeals court has ruled that Banner Life Sciences may make and market its version of Biogen’s blockbuster multiple sclerosis drug, Tecfidera (dimethyl fumarate). Read More
The FDA hit online pharmacy Unitedpharmacies.md with a warning letter for marketing on its website unapproved and misbranded products as COVID-19 treatments. Read More
The director of HHS’ Biomedical Advanced Research and Development Authority (BARDA), Rick Bright, has departed from the federal vaccine development agency to helm a new initiative on COVID-19 diagnostics at the National Institutes of Health (NIH). Read More
The FDA’s Coronavirus Treatment Acceleration Program is gearing up for a second wave of potential COVID-19 treatments and vaccines as the search for effective products gains momentum. Read More
The United Nations adopted a resolution calling for pharma companies to waive exclusive rights for their vaccines and treatments during the COVID-19 crisis. Read More
The European Medicines Agency (EMA) recommended that good manufacturing practice (GMP) certificates for drugmakers be extended until the end of 2021 to avoid potential drug supply-chain disruptions during the pandemic. Read More